Evidence map›Paper›PMID 41909902›Full record

ArticleGut microbes reports2025

The living medicine inside us:

K M Salim Andalib, Fabliha Bashashat Rodosy, Ahsan Habib

Abstract read
In one paragraph

Article in Gut microbes reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

K M Salim AndalibBiotechnology and Genetic Engineering Discipline, Life Science School, Khulna University, Khulna, Bangladesh.ORCID https://orcid.org/0000-0003-2181-6941
Fabliha Bashashat RodosyDepartment of Microbiology, Bhashasoinik Gaziul Haque Institute of Bioscience, Bogura, Bangladesh.ORCID https://orcid.org/0000-0002-9365-9095
Ahsan HabibBiotechnology and Genetic Engineering Discipline, Life Science School, Khulna University, Khulna, Bangladesh.ORCID https://orcid.org/0000-0002-1781-2166

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut microbial metabolism is intimately coupled to host health and disease. Recent knowledge on potential health benefits of gut microbiome lays the groundwork for development of novel therapeutic strategies. But how microbiota-derived metabolites impact on host-microbiome crosstalk remains untapped from therapeutic perspectives. In this study, six gut bacteria sourced from a fecal pool of forty healthy donors were cultured in three distinct growth media. Subsequently, the bacteria were identified through 16S rRNA gene sequencing and subjected to metabolite extraction to evaluate their anti-microbial, anti-oxidant and anti-thrombotic potential. Findings reveal strong anti-oxidant activities in the metabolic-extracts from all the isolates. Metabolites derived from

Indexed as

bacteria-derived metabolitesbiotherapeuticsGut bacteriagut healthprobioticstherapeutic prospects

Identifiers

PMID41909902
PMCPMC12940138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.